Modulation of innate immune responses during human T-cell leukemia virus (HTLV-1) pathogenesis
S Olière, R Douville, A Sze, SM Belgnaoui… - Cytokine & growth factor …, 2011 - Elsevier
Infection with the Human T-cell Leukemia virus type I (HTLV-1) retrovirus results in a number
of diverse pathologies, including the aggressive, fatal T-cell malignancy adult T-cell …
of diverse pathologies, including the aggressive, fatal T-cell malignancy adult T-cell …
Neurological aspects of HIV-1/HTLV-1 and HIV-1/HTLV-2 coinfection
AQC Araujo - Pathogens, 2020 - mdpi.com
Simultaneous infection by human immunodeficiency viruses (HIV) and human T-
lymphotropic viruses (HTLV) are not uncommon since they have similar means of …
lymphotropic viruses (HTLV) are not uncommon since they have similar means of …
Reversal of epigenetic silencing allows robust HIV-1 replication in the absence of integrase function
Integration of the proviral DNA intermediate into the host cell genome normally represents
an essential step in the retroviral life cycle. While the reason (s) for this requirement remains …
an essential step in the retroviral life cycle. While the reason (s) for this requirement remains …
[HTML][HTML] HTLV-1/2 seroprevalence and coinfection rate in Brazilian first-time blood donors: an 11-year follow-up
MT Pinto, ES Rodrigues, TM Malta… - Revista do Instituto de …, 2012 - SciELO Brasil
The seroprevalence and geographic distribution of HTLV-1/2 among blood donors are
extremely important to transfusion services. We evaluated the seroprevalence of HTLV-1/2 …
extremely important to transfusion services. We evaluated the seroprevalence of HTLV-1/2 …
Viral infections
INTRODUCTION This chapter consists of three sections. The first is an introductory section
entitled 'General Principles', which includes a general overview of neurovirology and a brief …
entitled 'General Principles', which includes a general overview of neurovirology and a brief …
Dynamics of HIV-1/HTLV-I co-infection model with humoral immunity and cellular infection
Human immunodeficiency virus type 1 (HIV-1) and human T-lymphotropic virus type I (HTLV-
I) are two retroviruses which infect the same target, CD 4+ T cells. This type of cell is …
I) are two retroviruses which infect the same target, CD 4+ T cells. This type of cell is …
CD4+ T-cell count may not be a useful strategy to monitor antiretroviral therapy response in HTLV-1/HIV co-infected patients
A Vandormael, F Rego, S Danaviah… - Current HIV …, 2017 - ingentaconnect.com
Background: HTLV-1/HIV co-infection is known to elevate the CD4+ T-cell counts of
treatment-naïve persons. We investigated whether HTLV-1/HIV co-infected patients …
treatment-naïve persons. We investigated whether HTLV-1/HIV co-infected patients …
Early and successful combination antiretroviral therapy normalizes survival time in patients coinfected with human immunodeficiency virus and human T-cell …
Background Coinfection with human T-cell lymphotrophic virus type 1 (HTLV-1) is
associated with shorter survival for adults and children infected with human …
associated with shorter survival for adults and children infected with human …
Molecular detection and clinical implications of HTLV-1 infections among antiretroviral therapy-naïve HIV-1-infected individuals in Abuja, Nigeria
IA Nasir, AE Ahmad, AU Emeribe… - Virology: research …, 2015 - journals.sagepub.com
Background Individuals with human T-cell lymphotrophic virus type-1 (HTLV-1)/HIV-1
coinfection have been demonstrated to undergo CD4+ lymphocytosis even in the face of …
coinfection have been demonstrated to undergo CD4+ lymphocytosis even in the face of …
Human T-cell leukemia virus type 1-related diseases may constitute a threat to the elimination of human immunodeficiency virus, by 2030, in Gabon, Central Africa
EF Oloumbou, JD Engone-Ondo… - Viruses, 2022 - mdpi.com
The Joint United Nations Program on HIV/AIDS (UNAIDS) has adopted the Sustainable
Development Goals (SDGs) to end the HIV/AIDS epidemic by 2030. Several factors related …
Development Goals (SDGs) to end the HIV/AIDS epidemic by 2030. Several factors related …